Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT05550805
What this trial is testing

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics (BIPass II)

Who this might be right for
Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
Qilu Hospital of Shandong University 5,822
Not applicableStudy completedNCT02364271
What this trial is testing

Early Risk Stratification in ED Chest Pain Patients

Who this might be right for
Acute Coronary Syndrome
Chinese University of Hong Kong 602
Large-scale testing (Phase 3)UnknownNCT00426049
What this trial is testing

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Who this might be right for
Coronary Artery DiseaseCoronary Restenosis
German Heart Institute 484
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Not applicableStudy completedNCT06644651
What this trial is testing

Fat Around Heart Arteries as a Measure of Inflammation in Patients With Diabetes

Who this might be right for
Atherosclerosis, CoronaryDiabetes MellitusDiabetes Mellitus Type 2+3 more
Odense University Hospital 314
Not applicableStudy completedNCT03740776
What this trial is testing

The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI

Who this might be right for
ST Elevation Myocardial Infarction
Dongying Zhang 2
Not applicableStudy completedNCT05487560
What this trial is testing

An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

Who this might be right for
Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
Hanmi Pharmaceutical Company Limited 4,133
Not applicableLooking for participantsNCT07366684
What this trial is testing

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Who this might be right for
ST Elevation (STEMI) Myocardial InfarctionNon ST Elevation Myocardial Infarction (NSTEMI)Unstable Angina Pectoris
Clinical Center Niš 550
Not applicableStudy completedNCT03746275
What this trial is testing

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Who this might be right for
Atherosclerosis
Bayer 5,798
Not applicableActive Not RecruitingNCT07432620
What this trial is testing

Artificial Intelligence Stress Echo (FINESSE) Project

Who this might be right for
Coronary Artery DiseaseChest PainMyocardial Ischemia+2 more
Milton Keynes University Hospital NHS Foundation Trust 2,281
Not applicableUnknownNCT05266547
What this trial is testing

Impact of OCT on Outcomes in AMI

Who this might be right for
Acute Myocardial Infarction
Beijing Luhe Hospital 1,600
Not applicableLooking for participantsNCT06951867
What this trial is testing

Tezspire Cardiac Events PASS

Who this might be right for
Cardiovascular EventsMACE
AstraZeneca 16,640
Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691
Post-approval studies (Phase 4)Looking for participantsNCT07719894
What this trial is testing

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atherosclerosis
Seoul National University Bundang Hospital 1,200
Not applicableLooking for participantsNCT06885619
What this trial is testing

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

Who this might be right for
Left Ventricular RemodelingPlasma Multi-OmicsAcute ST-segment Elevation Myocardial Infarction+2 more
Beijing Anzhen Hospital 1,000
Post-approval studies (Phase 4)UnknownNCT04100434
What this trial is testing

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Tianjin Chest Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT07448038
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Who this might be right for
Atherosclerosis
Genentech, Inc. 162
Post-approval studies (Phase 4)UnknownNCT00825773
What this trial is testing

Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions

Who this might be right for
IschemiaCardiac DeathMyocardial Infarction
JW Medical Systems Ltd 1,944
Early research (Phase 1)Ended earlyNCT00868855
What this trial is testing

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Vanderbilt University 16
Not applicableLooking for participantsNCT05378035
What this trial is testing

DOAC in Chinese Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeStroke, Acute+4 more
Chinese University of Hong Kong 427
Next Page